Skip to main content

Published locations for FDA approves sunitinib malate as adjuvant treatment for RCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves sunitinib malate as adjuvant treatment for RCC

User login

  • Reset your password
  • /content/fda-approves-sunitinib-malate-adjuvant-treatment-rcc
  • /oncologypractice/article/152335/renal-cell-carcinoma/fda-approves-sunitinib-malate-adjuvant
  • /hematology-oncology/article/152335/renal-cell-carcinoma/fda-approves-sunitinib-malate-adjuvant